EVP & General Mgr Industrial O of Regeneron Pharmaceuticals Inc (30-Year Financial, Insider Trades) Plew Daniel P Van (insider trades) sold 27,109 shares of REGN on 08/25/2020 at an average price of $610.89 a share. The total sale was $16.6 million.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron Pharmaceuticals Inc has a market cap of $65.43 billion; its shares were traded at around $614.97 with a P/E ratio of 23.79 and P/S ratio of 8.87. Regeneron Pharmaceuticals Inc had annual average EBITDA growth of 26.80% over the past five years. GuruFocus has detected 1 severe warning sign with Regeneron Pharmaceuticals Inc. .
CFO Recent Trades:
- EVP Finance CFO Robert E Landry sold 696 shares of REGN stock on 08/04/2020 at the average price of $654.46. The price of the stock has decreased by 6.03% since.
Directors and Officers Recent Trades:
- Director George L Sing sold 33,750 shares of REGN stock on 08/25/2020 at the average price of $607.42. The price of the stock has increased by 1.24% since.
- EVP & General Mgr Industrial O Plew Daniel P Van sold 27,109 shares of REGN stock on 08/25/2020 at the average price of $610.89. The price of the stock has increased by 0.67% since.
- Director George L Sing sold 61,000 shares of REGN stock on 08/24/2020 at the average price of $605.4. The price of the stock has increased by 1.58% since.
- Director Joseph L Goldstein sold 1,000 shares of REGN stock on 08/21/2020 at the average price of $617.18. The price of the stock has decreased by 0.36% since.
- Director P Roy Vagelos sold 33,460 shares of REGN stock on 08/11/2020 at the average price of $602.94. The price of the stock has increased by 2% since.
For the complete insider trading history of REGN, click here
.
